Concurrent Recording of Co-localized Electroencephalography and Local Field Potential in Rodent
November 30th, 2017
14.7K views
This protocol describes a simple method for concurrent recording of co-localized electroencephalography (EEG) and multi-laminar local field potential in an anesthetized rat. A burr hole drilled in the skull for the insertion of a microelectrode is shown to produce negligible distortion of the EEG signal.
Overview
This protocol describes a method for concurrent recording of electroencephalography (EEG) and multi-laminar local field potential (LFP) in an anesthetized rat. The technique provides insights into the relationship between EEG and LFP signals in the barrel cortex while ensuring minimal distortion of the EEG signal from the invasive procedure.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Experimental Models
Background
- Electroencephalography (EEG) provides valuable information on brain activity.
- Local field potentials (LFP) reflect synaptic activity in cortical layers.
- The study aims to simultaneously capture these signals in vivo.
Purpose of Study
- To develop a technique for recording co-localized EEG and LFP signals.
- To investigate the effects of surgical procedures on EEG signal integrity.
Methods Used
- Method involves surgery and electrode placements in anesthetized rats.
- The model used is an anesthetized rat, specifically focusing on the barrel cortex.
- The process includes drilling a burr hole for electrode insertion.
- Critical steps include temperature monitoring and careful electrode positioning.
Main Results
- Findings indicate that the EEG signal distortion from the burr hole is negligible.
- The LFP recorded is an order of magnitude larger than the ERP from EEG.
- The study confirms the relationship between the temporal profiles of the EEG and LFP.
Conclusions
- This study demonstrates a reliable method for recording EEG and LFP concurrently.
- The results provide insights into cortical signal interactions and influence future research on neurophysiological recordings.
Frequently Asked Questions
What are the advantages of this concurrent recording method?
This method allows for direct comparison of EEG and LFP signals, enhancing understanding of brain activity interactions without significant signal distortion.
How is the rat anesthetized for the procedure?
The rat is anesthetized using isoflurane in a chamber and maintained via a nose cone during the surgical process.
What types of data are obtained from this procedure?
The main data include EEG and LFP recordings, providing insights into neuronal excitability and cortical dynamics.
What steps are taken to ensure minimal disturbance to the EEG signal?
Careful surgical techniques, including minimizing burr hole size and monitoring electrode resistance, ensure the integrity of the EEG signal.
Can this technique be adapted for other brain regions?
Yes, while this protocol focuses on the barrel cortex, the approach can be modified for other cortical and subcortical areas.
What limitations are associated with this method?
One limitation is the invasive nature of the electrode insertion, which may introduce variability in signal quality.
Executive Industry Relevance
Concurrent EEG and LFP recording enables mechanistic de-risking in target validation by linking macroscopic brain signals to microcircuit activity. This approach improves predictive confidence in preclinical models of neurological disorders by clarifying the neurophysiological origins of EEG biomarkers. It supports translational biomarker development through cross-scale signal correlation in disease-relevant systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by correlating EEG biomarkers with layer-specific LFP activity in cortical circuits.
- Operational Value: Enables biological de-risking of targets through direct measurement of synaptic activity underlying non-invasive EEG readouts.
- Predictive Value: Supports portfolio triage by validating target engagement via co-localized electrophysiological signatures.
Screening & Assay Development
- Scientific Value: Prepares validated neural systems for assay standardization by establishing baseline EEG-LFP relationships.
- Operational Value: Enhances assay reproducibility through co-localized signal validation and minimal surgical artifact.
- Scalability: Supports platform reuse across studies via standardized burr hole and electrode placement procedures.
Translational & Preclinical Research
- Translational Continuity: Aligns EEG biomarkers with laminar LFP activity to improve disease model relevance.
- Mechanistic De-risking: Clarifies whether EEG changes reflect superficial or deep cortical processing in preclinical models.
- Risk-Adjusted Advancement: Informs go/no-go decisions by distinguishing signal origins in cortical layers.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical validation by linking non-invasive EEG readouts to invasive LFP measurements in rodent models of cortical function.
- Discovery Biology: Supports hypothesis testing by correlating EEG signals with microcircuit activity in specific cortical layers.
- Screening: Enables assay readiness through validated, reproducible EEG-LFP co-registration in anesthetized rodents.
- Analytics: Provides quantitative dependent variable measurements (EEG amplitude, LFP amplitude, peak latency) for cross-condition comparison.
- Translational Research: Connects EEG biomarkers to laminar-specific neural activity, supporting preclinical validation of network-level targets.
- Enterprise Reuse: Establishes a reusable capability for cross-project EEG-LFP correlation in sensory and cognitive neuroscience programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through mechanistic insight into EEG signal generation.
- Operational Value: Standardization and reproducibility via minimized burr hole impact and validated electrode placement.
- Strategic Value: Improved go/no-go decisions by reducing mechanistic ambiguity in EEG biomarker interpretation.
- Portfolio Impact: Risk-adjusted prioritization based on validated cortical origin of EEG signals.
Implementation Considerations
- Required expertise in rodent stereotaxic surgery and electrophysiological recording.
- Instrumentation needs include micromanipulator, multi-channel headstage, and EEG preamplifier.
- Cross-team standardization requires consistent burr hole size (<2mm) and electrode depth calibration.
- Adaptation considerations include adjusting coordinates for non-barrel cortical targets.
- Practical limitation: Invasive nature may limit longitudinal studies in the same animal.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in EEG-LFP studies?
Null hypothesis testing determines whether observed EEG-LFP correlations exceed chance levels, providing statistical rigor for target engagement claims. This ensures that biomarker changes reflect true biological effects rather than variability in signal acquisition. It supports go/no-go decisions by validating the reliability of co-localized measurements.
How does independent variable isolation fit the discovery pipeline in concurrent EEG-LFP recording?
Isolating independent variables (e.g., whisker stimulation) allows researchers to attribute EEG and LFP changes to specific sensory inputs, clarifying pathway-specific target effects. This supports mechanistic de-risking by linking stimuli to laminar-specific neural responses. It enables reproducible screening assays by controlling for confounding neural activity.
What quantitative dependent variable measurements enable cross-functional collaboration in EEG-LFP workflows?
Quantitative measures such as EEG amplitude, LFP amplitude, and peak latency differences between layers provide objective, comparable data across teams. These metrics support assay standardization and enable statistical comparison of drug or genetic effects on cortical processing. They facilitate translational discussions by offering a common electrophysiological language.
Why do replication requirements matter for cross-functional collaboration in EEG-LFP studies?
Replication ensures that EEG-LFP relationships are consistent across animals, reducing false positives in target validation. This builds confidence in biomarker reliability for multi-site preclinical studies. It supports regulatory-aligned data packages by demonstrating robustness of electrophysiological endpoints.
What statistical analysis capabilities are required before implementing concurrent EEG-LFP recording in discovery workflows?
Teams require capability to perform amplitude comparisons, latency measurements, and correlation analyses between EEG and LFP signals. This includes testing for significant differences in temporal profiles across cortical layers. Such analyses enable data-driven decisions about target mechanism and biomarker validity.
